Medication for childhood interstitial lung diseases differs internationally

S. Witt (Munich, Germany), B. Szentes (Munich, Germany), A. Bush (London, United Kingdom), S. Cunningham (Edinburgh, United Kingdom), N. Kiper (Ankara, Turkey), J. Lange (Warsaw, Poland), R. Leidl (Munich, Germany), S. Terheggen-Lagro (Amsterdam, Netherlands), N. Schwerk (Hannover, Germany), D. Snijders (Padova, Italy), M. Griese (Munich, Germany), L. Schwarzkopf (Munich, Germany)

Source: International Congress 2018 – Orphan diseases in children
Session: Orphan diseases in children
Session type: Poster Discussion
Number: 634
Disease area: Interstitial lung diseases, Paediatric lung diseases

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Witt (Munich, Germany), B. Szentes (Munich, Germany), A. Bush (London, United Kingdom), S. Cunningham (Edinburgh, United Kingdom), N. Kiper (Ankara, Turkey), J. Lange (Warsaw, Poland), R. Leidl (Munich, Germany), S. Terheggen-Lagro (Amsterdam, Netherlands), N. Schwerk (Hannover, Germany), D. Snijders (Padova, Italy), M. Griese (Munich, Germany), L. Schwarzkopf (Munich, Germany). Medication for childhood interstitial lung diseases differs internationally. 634

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: